GRCE
GRCE: Opaleye Management Inc. discloses a purchase
Opaleye Management Inc. reported Purchase in Grace Therapeutics, Inc.: 38796 units of Common Stock, par value $0.0001 per share, dated 2026-10-01. The full Form 4 contains 3 transaction entries.
